Topics

Erratum for "Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: a pharmacokinetic study".

08:00 EDT 1st August 2019 | BioPortfolio

Summary of "Erratum for "Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: a pharmacokinetic study"."

No Summary Available

Affiliation

Journal Details

This article was published in the following journal.

Name: International forum of allergy & rhinology
ISSN: 2042-6984
Pages: 944

Links

DeepDyve research library

PubMed Articles [20164 Associated PubMed Articles listed on BioPortfolio]

Erratum for "Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent".

Antibodies against the DNABII protein integration host factor (IHF) inhibit sinus implant biofilms.

Chronic rhinosinusitis is a common, costly condition often treated with endoscopic sinus surgery and intraoperative placement of intranasal sinus implant materials. Whereas these materials aid in post...

Twelve-month outcomes of a bioabsorbable implant for in-office treatment of dynamic nasal valve collapse.

To examine 12-month outcomes for in-office treatment of dynamic nasal valve collapse (NVC) with a bioabsorbable implant.

Implants in the Posterior Maxilla: Open Sinus Lift Versus Conventional Implant Placement. A Systematic Review.

To compare implant survival, marginal bone loss, peri-implant clinical parameters, and complications in dental implants placed in the posterior maxilla in native bone or after grafting using the open ...

Sinus Floor Elevation and Antrostomy Healing: A Histomorphometric Clinical Study in Humans.

To compare the histomorphometric outcomes of biopsies collected from the antrostomy and from the alveolar crest of the maxillary sinus after a sinus-lift procedure.

Clinical Trials [7917 Associated Clinical Trials listed on BioPortfolio]

The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery

Report on the technical feasibility and outcomes of in-office placement of PROPEL or PROPEL mini implants immediately following ethmoid sinus surgery

The PIO II Study of In-office Placement of a Steroid-eluting Sinus Implant

Randomized, controlled, double-blinded clinical trial with 40 patients randomized in 1:1 ratio to either treatment (bilateral in-office placement of Propel following ESS) or control (post ...

(PROGRESS) Safety and Efficacy of the Propel Mini Steroid-Eluting Sinus Implant in Frontal Sinus

The objective of the PROGRESS Study is to assess the safety and efficacy of the Propel Mini steroid-eluting Sinus Implant when placed in the frontal sinus opening following frontal sinus s...

Comparison of Two Steroid Nasal Implants Following Endoscopic Sinus Surgery for Chronic Rhinosinusitis

The purpose of this study is to learn whether there is a difference in postoperative (after surgery) endoscopic appearance of the sinus cavities (the way that the sinuses look through a ca...

RESOLVE II Clinical Evaluation of Safety and Efficacy of S8 Sinus Implant in Chronic Sinusitis Patients

The RESOLVE II Study will assess the safety and efficacy of the steroid-releasing S8 Sinus Implant when used in post-sinus surgery patients who present with recurrent sinus obstruction. Th...

Medical and Biotech [MESH] Definitions

Guided BONE TRANSPLANTATION of the MAXILLARY SINUS surface with a BONE SUBSTITUTE grafting. It increases the bone volume at the site of the DENTAL IMPLANT and helps stabilize it.

Air-filled spaces located within the bones around the NASAL CAVITY. They are extensions of the nasal cavity and lined by the ciliated NASAL MUCOSA. Each sinus is named for the cranial bone in which it is located, such as the ETHMOID SINUS; the FRONTAL SINUS; the MAXILLARY SINUS; and the SPHENOID SINUS.

Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.

An office of the UNITED STATES PUBLIC HEALTH SERVICE organized in June 1992 to promote research integrity and investigate misconduct in research supported by the Public Health Service. It consolidates the Office of Scientific Integrity of the National Institutes of Health and the Office of Scientific Integrity Review in the Office of the Assistant Secretary for Health.

An office established to help Congress participate and plan for the consequences of uses of technology. It provided information on both the beneficial and adverse effects of technological applications. The Office of Technology Assessment closed on September 29, 1995.

Quick Search


DeepDyve research library

Searches Linking to this Article